{"entity":{"type":"insider","cik":"0001253828","url":"/insider/0001253828","json_url":"/insider/0001253828.json","name":"ADAMS MICHAEL F","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":36,"n_filings":25,"first":"2003-12-30","last":"2017-08-25","span_basis":"filed_date"},"name_variants":[{"name":"ADAMS MICHAEL F","source":"filing","n_filings":25,"first_seen":"2003-12-30","last_seen":"2017-08-25"}],"transactions":[{"id":5312539,"accession":"0001011060-17-000028","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001011060-17-000028","line_url":"/filing/0001011060-17-000028#line-1","is_derivative":false,"issuer_cik":"0001011060","issuer_name":"AdvanSource Biomaterials Corp","issuer_ticker":"ASNB","issuer_name_source":null,"issuer_url":"/issuer/0001011060","owner_cik":"0001253828","owner_name":"ADAMS MICHAEL F","owner_display_name":"ADAMS MICHAEL F","owner_url":"/insider/0001253828","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.08,"price_display":"0.08","price_state":"stated","total_value":800.0,"total_display":"800.00","total_whole":"800","shares_owned_after":609934.0,"shares_owned_after_display":"609,934","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-23","filed_date":"2017-08-25","scope":"insider"},{"id":4070796,"accession":"0001011060-17-000027","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001011060-17-000027","line_url":"/filing/0001011060-17-000027#line-1","is_derivative":false,"issuer_cik":"0001011060","issuer_name":"AdvanSource Biomaterials Corp","issuer_ticker":"ASNB","issuer_name_source":null,"issuer_url":"/issuer/0001011060","owner_cik":"0001253828","owner_name":"ADAMS MICHAEL F","owner_display_name":"ADAMS MICHAEL F","owner_url":"/insider/0001253828","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.065,"price_display":"0.06","price_state":"stated","total_value":650.0,"total_display":"650.00","total_whole":"650","shares_owned_after":599934.0,"shares_owned_after_display":"599,934","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-21","filed_date":"2017-08-23","scope":"insider"},{"id":8798119,"accession":"0001011060-15-000026","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001011060-15-000026","line_url":"/filing/0001011060-15-000026#line-1","is_derivative":false,"issuer_cik":"0001011060","issuer_name":"AdvanSource Biomaterials Corp","issuer_ticker":"ASNB","issuer_name_source":null,"issuer_url":"/issuer/0001011060","owner_cik":"0001253828","owner_name":"ADAMS MICHAEL F","owner_display_name":"ADAMS MICHAEL F","owner_url":"/insider/0001253828","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.145,"price_display":"0.14","price_state":"stated","total_value":1450.0,"total_display":"1,450.00","total_whole":"1,450","shares_owned_after":589934.0,"shares_owned_after_display":"589,934","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-30","filed_date":"2015-12-01","scope":"insider"},{"id":8197582,"accession":"0001011060-15-000020","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001011060-15-000020","line_url":"/filing/0001011060-15-000020#line-1","is_derivative":false,"issuer_cik":"0001011060","issuer_name":"AdvanSource Biomaterials Corp","issuer_ticker":"ASNB","issuer_name_source":null,"issuer_url":"/issuer/0001011060","owner_cik":"0001253828","owner_name":"ADAMS MICHAEL F","owner_display_name":"ADAMS MICHAEL F","owner_url":"/insider/0001253828","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":0.1265,"price_display":"0.13","price_state":"stated","total_value":632.5,"total_display":"632.50","total_whole":"633","shares_owned_after":579934.0,"shares_owned_after_display":"579,934","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-20","filed_date":"2015-08-24","scope":"insider"},{"id":8856839,"accession":"0001011060-15-000017","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001011060-15-000017","line_url":"/filing/0001011060-15-000017#line-1","is_derivative":false,"issuer_cik":"0001011060","issuer_name":"AdvanSource Biomaterials Corp","issuer_ticker":"ASNB","issuer_name_source":null,"issuer_url":"/issuer/0001011060","owner_cik":"0001253828","owner_name":"ADAMS MICHAEL F","owner_display_name":"ADAMS MICHAEL F","owner_url":"/insider/0001253828","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":0.125,"price_display":"0.12","price_state":"stated","total_value":250.0,"total_display":"250.00","total_whole":"250","shares_owned_after":561834.0,"shares_owned_after_display":"561,834","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-19","filed_date":"2015-08-21","scope":"insider"},{"id":8837982,"accession":"0001011060-15-000019","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001011060-15-000019","line_url":"/filing/0001011060-15-000019","is_derivative":false,"issuer_cik":"0001011060","issuer_name":"AdvanSource Biomaterials Corp","issuer_ticker":"ASNB","issuer_name_source":null,"issuer_url":"/issuer/0001011060","owner_cik":"0001253828","owner_name":"ADAMS MICHAEL F","owner_display_name":"ADAMS MICHAEL F","owner_url":"/insider/0001253828","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10600.0,"shares_display":"10,600","price_per_share":0.12867924528301886,"price_display":"0.13","price_state":"stated","total_value":1364.0,"total_display":"1,364.00","total_whole":"1,364","shares_owned_after":569934.0,"shares_owned_after_display":"569,934","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-19","filed_date":"2015-08-21","scope":"insider","n_lines":2},{"id":8779267,"accession":"0001011060-15-000018","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001011060-15-000018","line_url":"/filing/0001011060-15-000018#line-1","is_derivative":false,"issuer_cik":"0001011060","issuer_name":"AdvanSource Biomaterials Corp","issuer_ticker":"ASNB","issuer_name_source":null,"issuer_url":"/issuer/0001011060","owner_cik":"0001253828","owner_name":"ADAMS MICHAEL F","owner_display_name":"ADAMS MICHAEL F","owner_url":"/insider/0001253828","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":0.1265,"price_display":"0.13","price_state":"stated","total_value":316.25,"total_display":"316.25","total_whole":"316","shares_owned_after":564334.0,"shares_owned_after_display":"564,334","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-19","filed_date":"2015-08-21","scope":"insider"},{"id":9215186,"accession":"0001011060-15-000016","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001011060-15-000016","line_url":"/filing/0001011060-15-000016#line-1","is_derivative":false,"issuer_cik":"0001011060","issuer_name":"AdvanSource Biomaterials Corp","issuer_ticker":"ASNB","issuer_name_source":null,"issuer_url":"/issuer/0001011060","owner_cik":"0001253828","owner_name":"ADAMS MICHAEL F","owner_display_name":"ADAMS MICHAEL F","owner_url":"/insider/0001253828","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.096,"price_display":"0.10","price_state":"stated","total_value":960.0,"total_display":"960.00","total_whole":"960","shares_owned_after":559834.0,"shares_owned_after_display":"559,834","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-18","filed_date":"2015-08-21","scope":"insider"},{"id":8687999,"accession":"0001011060-15-000015","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001011060-15-000015","line_url":"/filing/0001011060-15-000015","is_derivative":false,"issuer_cik":"0001011060","issuer_name":"AdvanSource Biomaterials Corp","issuer_ticker":"ASNB","issuer_name_source":null,"issuer_url":"/issuer/0001011060","owner_cik":"0001253828","owner_name":"ADAMS MICHAEL F","owner_display_name":"ADAMS MICHAEL F","owner_url":"/insider/0001253828","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10130.0,"shares_display":"10,130","price_per_share":0.9487068114511352,"price_display":"0.95","price_state":"stated","total_value":9610.4,"total_display":"9,610.40","total_whole":"9,610","shares_owned_after":559834.0,"shares_owned_after_display":"559,834","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-18","filed_date":"2015-08-20","scope":"insider","n_lines":2},{"id":4484837,"accession":"0001011060-13-000047","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001011060-13-000047","line_url":"/filing/0001011060-13-000047#line-1","is_derivative":false,"issuer_cik":"0001011060","issuer_name":"AdvanSource Biomaterials Corp","issuer_ticker":"ASNB","issuer_name_source":null,"issuer_url":"/issuer/0001011060","owner_cik":"0001253828","owner_name":"ADAMS MICHAEL F","owner_display_name":"ADAMS MICHAEL F","owner_url":"/insider/0001253828","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.06,"price_display":"0.06","price_state":"stated","total_value":600.0,"total_display":"600.00","total_whole":"600","shares_owned_after":549704.0,"shares_owned_after_display":"549,704","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-12-13","filed_date":"2013-12-16","scope":"insider"},{"id":4517095,"accession":"0001011060-13-000046","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001011060-13-000046","line_url":"/filing/0001011060-13-000046#line-1","is_derivative":false,"issuer_cik":"0001011060","issuer_name":"AdvanSource Biomaterials Corp","issuer_ticker":"ASNB","issuer_name_source":null,"issuer_url":"/issuer/0001011060","owner_cik":"0001253828","owner_name":"ADAMS MICHAEL F","owner_display_name":"ADAMS MICHAEL F","owner_url":"/insider/0001253828","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12500.0,"shares_display":"12,500","price_per_share":0.058,"price_display":"0.06","price_state":"stated","total_value":725.0,"total_display":"725.00","total_whole":"725","shares_owned_after":539704.0,"shares_owned_after_display":"539,704","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-12-10","filed_date":"2013-12-13","scope":"insider"},{"id":5469766,"accession":"0001011060-13-000045","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001011060-13-000045","line_url":"/filing/0001011060-13-000045#line-1","is_derivative":false,"issuer_cik":"0001011060","issuer_name":"AdvanSource Biomaterials Corp","issuer_ticker":"ASNB","issuer_name_source":null,"issuer_url":"/issuer/0001011060","owner_cik":"0001253828","owner_name":"ADAMS MICHAEL F","owner_display_name":"ADAMS MICHAEL F","owner_url":"/insider/0001253828","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":0.052,"price_display":"0.05","price_state":"stated","total_value":1040.0,"total_display":"1,040.00","total_whole":"1,040","shares_owned_after":527204.0,"shares_owned_after_display":"527,204","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-12-09","filed_date":"2013-12-10","scope":"insider"},{"id":5436161,"accession":"0001011060-13-000043","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001011060-13-000043","line_url":"/filing/0001011060-13-000043","is_derivative":false,"issuer_cik":"0001011060","issuer_name":"AdvanSource Biomaterials Corp","issuer_ticker":"ASNB","issuer_name_source":null,"issuer_url":"/issuer/0001011060","owner_cik":"0001253828","owner_name":"ADAMS MICHAEL F","owner_display_name":"ADAMS MICHAEL F","owner_url":"/insider/0001253828","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7500.0,"shares_display":"7,500","price_per_share":0.04933333333333333,"price_display":"0.05","price_state":"stated","total_value":370.0,"total_display":"370.00","total_whole":"370","shares_owned_after":504704.0,"shares_owned_after_display":"504,704","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-12-04","filed_date":"2013-12-06","scope":"insider","n_lines":2},{"id":5436157,"accession":"0001011060-13-000043","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001011060-13-000043","line_url":"/filing/0001011060-13-000043#line-1","is_derivative":false,"issuer_cik":"0001011060","issuer_name":"AdvanSource Biomaterials Corp","issuer_ticker":"ASNB","issuer_name_source":null,"issuer_url":"/issuer/0001011060","owner_cik":"0001253828","owner_name":"ADAMS MICHAEL F","owner_display_name":"ADAMS MICHAEL F","owner_url":"/insider/0001253828","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.051,"price_display":"0.05","price_state":"stated","total_value":510.0,"total_display":"510.00","total_whole":"510","shares_owned_after":499704.0,"shares_owned_after_display":"499,704","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-12-03","filed_date":"2013-12-06","scope":"insider"},{"id":4484831,"accession":"0001011060-13-000038","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001011060-13-000038","line_url":"/filing/0001011060-13-000038#line-1","is_derivative":false,"issuer_cik":"0001011060","issuer_name":"AdvanSource Biomaterials Corp","issuer_ticker":"ASNB","issuer_name_source":null,"issuer_url":"/issuer/0001011060","owner_cik":"0001253828","owner_name":"ADAMS MICHAEL F","owner_display_name":"ADAMS MICHAEL F","owner_url":"/insider/0001253828","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":28224.0,"shares_display":"28,224","price_per_share":0.065,"price_display":"0.06","price_state":"stated","total_value":1834.56,"total_display":"1,834.56","total_whole":"1,835","shares_owned_after":489704.0,"shares_owned_after_display":"489,704","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-09-06","filed_date":"2013-09-09","scope":"insider"},{"id":2539460,"accession":"0001011060-12-000053","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001011060-12-000053","line_url":"/filing/0001011060-12-000053","is_derivative":false,"issuer_cik":"0001011060","issuer_name":"AdvanSource Biomaterials Corp","issuer_ticker":"ASNB","issuer_name_source":null,"issuer_url":"/issuer/0001011060","owner_cik":"0001253828","owner_name":"ADAMS MICHAEL F","owner_display_name":"ADAMS MICHAEL F","owner_url":"/insider/0001253828","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50464.0,"shares_display":"50,464","price_per_share":0.0428060597653773,"price_display":"0.04","price_state":"stated","total_value":2160.165,"total_display":"2,160.16","total_whole":"2,160","shares_owned_after":441216.0,"shares_owned_after_display":"441,216","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-12-14","filed_date":"2012-12-17","scope":"insider","n_lines":3},{"id":3486590,"accession":"0001011060-12-000052","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001011060-12-000052","line_url":"/filing/0001011060-12-000052#line-1","is_derivative":false,"issuer_cik":"0001011060","issuer_name":"AdvanSource Biomaterials Corp","issuer_ticker":"ASNB","issuer_name_source":null,"issuer_url":"/issuer/0001011060","owner_cik":"0001253828","owner_name":"ADAMS MICHAEL F","owner_display_name":"ADAMS MICHAEL F","owner_url":"/insider/0001253828","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":0.04,"price_display":"0.04","price_state":"stated","total_value":200.0,"total_display":"200.00","total_whole":"200","shares_owned_after":411016.0,"shares_owned_after_display":"411,016","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-12-10","filed_date":"2012-12-12","scope":"insider"},{"id":3463201,"accession":"0001011060-12-000050","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001011060-12-000050","line_url":"/filing/0001011060-12-000050#line-1","is_derivative":false,"issuer_cik":"0001011060","issuer_name":"AdvanSource Biomaterials Corp","issuer_ticker":"ASNB","issuer_name_source":null,"issuer_url":"/issuer/0001011060","owner_cik":"0001253828","owner_name":"ADAMS MICHAEL F","owner_display_name":"ADAMS MICHAEL F","owner_url":"/insider/0001253828","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":0.032,"price_display":"0.03","price_state":"stated","total_value":640.0,"total_display":"640.00","total_whole":"640","shares_owned_after":406016.0,"shares_owned_after_display":"406,016","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-12-06","filed_date":"2012-12-10","scope":"insider"},{"id":2775110,"accession":"0001011060-12-000049","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001011060-12-000049","line_url":"/filing/0001011060-12-000049","is_derivative":false,"issuer_cik":"0001011060","issuer_name":"AdvanSource Biomaterials Corp","issuer_ticker":"ASNB","issuer_name_source":null,"issuer_url":"/issuer/0001011060","owner_cik":"0001253828","owner_name":"ADAMS MICHAEL F","owner_display_name":"ADAMS MICHAEL F","owner_url":"/insider/0001253828","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":0.0425,"price_display":"0.04","price_state":"stated","total_value":850.0,"total_display":"850.00","total_whole":"850","shares_owned_after":386016.0,"shares_owned_after_display":"386,016","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-12-04","filed_date":"2012-12-06","scope":"insider","n_lines":2},{"id":2479952,"accession":"0001011060-12-000048","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001011060-12-000048","line_url":"/filing/0001011060-12-000048#line-1","is_derivative":false,"issuer_cik":"0001011060","issuer_name":"AdvanSource Biomaterials Corp","issuer_ticker":"ASNB","issuer_name_source":null,"issuer_url":"/issuer/0001011060","owner_cik":"0001253828","owner_name":"ADAMS MICHAEL F","owner_display_name":"ADAMS MICHAEL F","owner_url":"/insider/0001253828","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7061.0,"shares_display":"7,061","price_per_share":0.035,"price_display":"0.04","price_state":"stated","total_value":247.135,"total_display":"247.14","total_whole":"247","shares_owned_after":366016.0,"shares_owned_after_display":"366,016","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-12-03","filed_date":"2012-12-05","scope":"insider"},{"id":3110871,"accession":"0001011060-12-000045","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001011060-12-000045","line_url":"/filing/0001011060-12-000045#line-2","is_derivative":false,"issuer_cik":"0001011060","issuer_name":"AdvanSource Biomaterials Corp","issuer_ticker":"ASNB","issuer_name_source":null,"issuer_url":"/issuer/0001011060","owner_cik":"0001253828","owner_name":"ADAMS MICHAEL F","owner_display_name":"ADAMS MICHAEL F","owner_url":"/insider/0001253828","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7400.0,"shares_display":"7,400","price_per_share":0.035,"price_display":"0.04","price_state":"stated","total_value":259.0,"total_display":"259.00","total_whole":"259","shares_owned_after":358955.0,"shares_owned_after_display":"358,955","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-11-27","filed_date":"2012-11-28","scope":"insider"},{"id":3110865,"accession":"0001011060-12-000045","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001011060-12-000045","line_url":"/filing/0001011060-12-000045#line-1","is_derivative":false,"issuer_cik":"0001011060","issuer_name":"AdvanSource Biomaterials Corp","issuer_ticker":"ASNB","issuer_name_source":null,"issuer_url":"/issuer/0001011060","owner_cik":"0001253828","owner_name":"ADAMS MICHAEL F","owner_display_name":"ADAMS MICHAEL F","owner_url":"/insider/0001253828","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":481.0,"shares_display":"481","price_per_share":0.02,"price_display":"0.02","price_state":"stated","total_value":9.62,"total_display":"9.62","total_whole":"10","shares_owned_after":351555.0,"shares_owned_after_display":"351,555","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-11-26","filed_date":"2012-11-28","scope":"insider"},{"id":3160524,"accession":"0001011060-12-000043","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001011060-12-000043","line_url":"/filing/0001011060-12-000043#line-3","is_derivative":false,"issuer_cik":"0001011060","issuer_name":"AdvanSource Biomaterials Corp","issuer_ticker":"ASNB","issuer_name_source":null,"issuer_url":"/issuer/0001011060","owner_cik":"0001253828","owner_name":"ADAMS MICHAEL F","owner_display_name":"ADAMS MICHAEL F","owner_url":"/insider/0001253828","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9732.0,"shares_display":"9,732","price_per_share":0.045,"price_display":"0.04","price_state":"stated","total_value":437.94,"total_display":"437.94","total_whole":"438","shares_owned_after":350806.0,"shares_owned_after_display":"350,806","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-11-20","filed_date":"2012-11-21","scope":"insider"},{"id":3160520,"accession":"0001011060-12-000043","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001011060-12-000043","line_url":"/filing/0001011060-12-000043","is_derivative":false,"issuer_cik":"0001011060","issuer_name":"AdvanSource Biomaterials Corp","issuer_ticker":"ASNB","issuer_name_source":null,"issuer_url":"/issuer/0001011060","owner_cik":"0001253828","owner_name":"ADAMS MICHAEL F","owner_display_name":"ADAMS MICHAEL F","owner_url":"/insider/0001253828","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20268.0,"shares_display":"20,268","price_per_share":0.03986777185711466,"price_display":"0.04","price_state":"stated","total_value":808.04,"total_display":"808.04","total_whole":"808","shares_owned_after":341074.0,"shares_owned_after_display":"341,074","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-11-19","filed_date":"2012-11-21","scope":"insider","n_lines":2},{"id":2267671,"accession":"0001558093-12-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001558093-12-000002","line_url":"/filing/0001558093-12-000002#line-2","is_derivative":false,"issuer_cik":"0001011060","issuer_name":"AdvanSource Biomaterials Corp","issuer_ticker":"ASNB","issuer_name_source":null,"issuer_url":"/issuer/0001011060","owner_cik":"0001253828","owner_name":"ADAMS MICHAEL F","owner_display_name":"ADAMS MICHAEL F","owner_url":"/insider/0001253828","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":0.02,"price_display":"0.02","price_state":"stated","total_value":400.0,"total_display":"400.00","total_whole":"400","shares_owned_after":291074.0,"shares_owned_after_display":"291,074","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-09-14","filed_date":"2012-09-19","scope":"insider"},{"id":2267665,"accession":"0001558093-12-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001558093-12-000002","line_url":"/filing/0001558093-12-000002#line-1","is_derivative":false,"issuer_cik":"0001011060","issuer_name":"AdvanSource Biomaterials Corp","issuer_ticker":"ASNB","issuer_name_source":null,"issuer_url":"/issuer/0001011060","owner_cik":"0001253828","owner_name":"ADAMS MICHAEL F","owner_display_name":"ADAMS MICHAEL F","owner_url":"/insider/0001253828","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30000.0,"shares_display":"30,000","price_per_share":0.04,"price_display":"0.04","price_state":"stated","total_value":1200.0,"total_display":"1,200.00","total_whole":"1,200","shares_owned_after":321074.0,"shares_owned_after_display":"321,074","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-08-18","filed_date":"2012-09-19","scope":"insider"},{"id":3627050,"accession":"0001140361-08-015199","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-08-015199","line_url":"/filing/0001140361-08-015199#line-1","is_derivative":false,"issuer_cik":"0001011060","issuer_name":"CARDIOTECH INTERNATIONAL INC","issuer_ticker":"CTE","issuer_name_source":null,"issuer_url":"/issuer/0001011060","owner_cik":"0001253828","owner_name":"ADAMS MICHAEL F","owner_display_name":"ADAMS MICHAEL F","owner_url":"/insider/0001253828","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"common stcok","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":383.0,"shares_display":"383","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":383.0,"shares_owned_after_display":"383","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-03-28","filed_date":"2008-06-18","scope":"insider"},{"id":3627049,"accession":"0001140361-08-015141","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-08-015141","line_url":"/filing/0001140361-08-015141#line-1","is_derivative":false,"issuer_cik":"0001011060","issuer_name":"CARDIOTECH INTERNATIONAL INC","issuer_ticker":"CTE","issuer_name_source":null,"issuer_url":"/issuer/0001011060","owner_cik":"0001253828","owner_name":"ADAMS MICHAEL F","owner_display_name":"ADAMS MICHAEL F","owner_url":"/insider/0001253828","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"common stcok","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":383.0,"shares_display":"383","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":383.0,"shares_owned_after_display":"383","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-03-28","filed_date":"2008-06-17","scope":"insider"},{"id":128589,"accession":"0001104659-03-029347","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-03-029347","line_url":"/filing/0001104659-03-029347#line-1","is_derivative":false,"issuer_cik":"0001011060","issuer_name":"CARDIOTECH INTERNATIONAL INC","issuer_ticker":"CTE","issuer_name_source":null,"issuer_url":"/issuer/0001011060","owner_cik":"0001253828","owner_name":"ADAMS MICHAEL F","owner_display_name":"ADAMS MICHAEL F","owner_url":"/insider/0001253828","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":0.5,"price_display":"0.50","price_state":"stated","total_value":15000.0,"total_display":"15,000.00","total_whole":"15,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2003-12-16","filed_date":"2003-12-30","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":36,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":35,"open_market":true},{"code":"S","label":"Open-market sale","n":1,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":36},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001011060","name":"AdvanSource Biomaterials Corp","url":"/issuer/0001011060","role":"Director, Officer (CEO and President)","n_filings":25,"first_seen":"2003-12-30","last_seen":"2017-08-25"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001253828","retrieved_at":"2026-08-27T00:39:30+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}